12 November, 2021 by The TZ Newswire Staff Comments Off on Fauci Warned About Coronaviruses In 2003 – But Didn’t Act On It
Fauci Warned About Coronaviruses In 2003 – But Didn’t Act On It
Fauci Warned About Coronaviruses In 2003 – But Didn’t Act On It
12 November, 2021 by The TZ Newswire Staff Comments Off on Is ServiceNow Stock a Smart Buy?
Is ServiceNow Stock a Smart Buy?
ServiceNow (NYSE: NOW) helps businesses manage complex workflows, a value proposition made all the more compelling by digital transformation. In this Backstage Pass video, which aired Oct. 27, 2021, Motley Fool contributors Nick Rossolillo and Brian Withers discuss the company’s third-quarter earnings, while also weighing in on its prospects as long-term investment.
12 November, 2021 by The TZ Newswire Staff Comments Off on Coupang, Inc. (CPNG) Q3 2021 Earnings Call Transcript
Coupang, Inc. (CPNG) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool.
Coupang, Inc. (NYSE: CPNG)
Q3 2021 Earnings Call
Nov 12, 2021, 7:00 a.m. ET
Operator
12 November, 2021 by The TZ Newswire Staff Comments Off on Watch: Sikorsky’s S-97 Raider Flies 247 Knots As Flight Envelope Expands
Watch: Sikorsky’s S-97 Raider Flies 247 Knots As Flight Envelope Expands
Watch: Sikorsky’s S-97 Raider Flies 247 Knots As Flight Envelope Expands
Sikorsky S-97 Raider is a one-of-a-kind helicopter part of the US Army’s Future Vertical Lift Program.
The S-97 Raider prototype is part of Sikorsky’s entry into the Future Attack Reconnaissance Aircraft competition for the Army to replace the aging UH-60 Black Hawk and Apache attack helicopters in the coming years.
12 November, 2021 by The TZ Newswire Staff Comments Off on Vaccitech의 VTP-300, 건강한 지원자 및 만성B형간염 환자 모두가 보유한 모든 표적 HBV 항원에 대해 우수한 내약성 및 T세포 유도 능력 보였다는 초기 결과 발표
Vaccitech의 VTP-300, 건강한 지원자 및 만성B형간염 환자 모두가 보유한 모든 표적 HBV 항원에 대해 우수한 내약성 및 T세포 유도 능력 보였다는 초기 결과 발표
HBV001 및 HBV002 연구의 초기 데이터, 만성B형간염(CHB) 환자의 경우 이종 프라임-부스트 벡터 조합인 ChAdOx1-HBV + MVA-HBV (VTP-300)가 B형간염 바이러스 항원 표적에 대해 강력한 T세포 면역 반응 유도
12 November, 2021 by The TZ Newswire Staff Comments Off on 在中期分析中，Vaccitech的VTP-300对健康志愿者和慢性HBV感染患者中都具有良好耐受性，并可诱发T细胞对抗所有靶向HBV抗原
在中期分析中，Vaccitech的VTP-300对健康志愿者和慢性HBV感染患者中都具有良好耐受性，并可诱发T细胞对抗所有靶向HBV抗原
HBV001和HBV002这两项研究的中期数据表明，在慢性乙型肝炎（CHB）患者中，ChAdOx1-HBV + MVA-HBV（VTP-300）的异源初免-加强载体组合诱发T细胞积极对抗靶向乙型肝炎病毒抗原。
12 November, 2021 by The TZ Newswire Staff Comments Off on Medical Research Rapidly Adopts “Systemic Racism” As Truth, Risking Scientific Credibility, Part 1
Medical Research Rapidly Adopts “Systemic Racism” As Truth, Risking Scientific Credibility, Part 1
Medical Research Rapidly Adopts “Systemic Racism” As Truth, Risking Scientific Credibility, Part 1
By John Murawski of RealClearInvestigations, Part 1 of 2